The findings revealed that the HBM-based interventions reduced the levels of anxiety and depression in COPD patients, as well as the COPD Assessment Test scores, and also decreased levels of serum interleukin-6 and C-reactive protein in the experimental group. Here, IL6 is linked to chronic obstructive pulmonary disease.